Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cepacol Teen Mouthwash in Adolescents
NCT00729599Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- Aug 2008
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetylpyridinium chloride in dental plaque, gingivitis, sponsored by Sanofi. Started Jul 2008; status: completed.
02
Drugs
cetylpyridinium chloride
03
Conditions
dental plaquegingivitis
Beyond the preview
Go deeper on NCT00729599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729599.